Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s13760-022-02003-1 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Corrigendum: A practical approach to in-hospital management of new-onset refractory status epilepticus/febrile infection related epilepsy syndrome.
Front Neurol
November 2024
Epilepsy Division, Department of Neurology, Yale School of Medicine, New Haven, CT, United States.
[This corrects the article DOI: 10.3389/fneur.2023.
View Article and Find Full Text PDFAuthor Correction: Anakinra in Sanfilippo syndrome: a phase 1/2 trial.
Nat Med
September 2024
Department of Pediatrics, University of Minnesota Medical School, Minneapolis, MN, USA.
Research Letter: Relationship of Blood Biomarkers of Inflammation With Acute Concussion Symptoms and Recovery in the CARE Consortium.
J Head Trauma Rehabil
January 2025
Author Affiliations: Department of Neurosurgery (Dr Meier, Mr Huber, and Dr McCrea), Department of Biomedical Engineering (Dr Meier), Department of Biophysics (Ms Goeckner), Department of Cell Biology, Neurobiology and Anatomy (Dr Meier), Department of Neurology (Dr McCrea), Medical College of Wisconsin, Milwaukee, Wisconsin; National Institute of Nursing Research (Dr Gill), National Institutes of Health, Bethesda, Maryland, USA; Johns Hopkins School of Nursing and Medicine (Dr Gill), Baltimore, MD; Department of Physical Medicine and Rehabilitation (Dr Pasquina), Uniformed Services University of the Health Sciences, Bethesda, Maryland; Michigan Concussion Center (Dr Broglio), University of Michigan, Ann Arbor, Michigan; Department of Psychiatry (Dr McAllister), Indiana University School of Medicine, Indianapolis, IN; and Department of Epidemiology and Biostatistics (Dr Harezlak), School of Public Health-Bloomington, Indiana University, Bloomington, Indiana.
Article Synopsis
- This study aimed to investigate the link between inflammatory biomarkers and recovery indicators in college athletes suffering from concussions.
- Conducted across multiple NCAA institutions, 422 participants were assessed with various clinical measures at different time points post-injury, focusing on multiple inflammatory markers in their blood.
- Results indicated that certain inflammatory markers, particularly IL-1RA and TNF, were associated with worse cognitive symptoms and recovery outcomes, especially in female athletes; however, similar associations were not found in nonathlete groups.
Gut Immunomodulation with Vedolizumab prior to Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients with Inflammatory Bowel Disease.
Transplant Cell Ther
May 2024
Division of Hematology/Oncology, Blood and Marrow Transplant/Cellular Therapy, Hospital for Sick Children, Toronto, Ontario, Canada.
Inborn errors of immunity (IEI) are often associated with inflammatory bowel disease (IBD). IEI can be corrected by allogeneic hematopoietic stem cell transplantation (HSCT); however, peritransplantation intestinal inflammation may increase the risk of gut graft-versus-host disease (GVHD). Vedolizumab inhibits the homing of lymphocytes to the intestine and may attenuate gut GVHD, yet its role in preventing GVHD in pediatric patients with IEI-associated IBD has not been studied.
View Article and Find Full Text PDFMacrophage activation syndrome with acute hepatitis in a patient with adult-onset immunodeficiency with anti-interferon gamma antibodies: a case report.
J Med Case Rep
January 2024
Division of Gastroenterology, Hepatology, & Nutrition, Department of Medicine, University of Minnesota, Minneapolis, MN, USA.
Background: Macrophage activation syndrome is a rare disorder leading to unregulated immune activity manifesting with nonspecific constitutional symptoms, laboratory abnormalities, and multiorgan involvement. We report the case of a patient who presented with acute hepatitis secondary to macrophage activation syndrome diagnosed by liver biopsy and successfully treated with intravenous immune globulin, anakinra, and rituximab.
Case Presentation: A 42-year-old Laotian woman with adult-onset immunodeficiency with anti-interferon gamma antibodies presented with a fever, headache, generalized myalgia, dark urine, and reduced appetite in the setting of family members at home with similar symptoms.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!